Influence of Metabolic, Transporter, and Pathogenic Genes on Pharmacogenetics and DNA Methylation in Neurological Disorders
Pharmacogenetics and DNA methylation influence therapeutic outcomes and provide insights into potential therapeutic targets for brain-related disorders. To understand the effect of genetic polymorphisms on drug response and disease risk, we analyzed the relationship between global DNA methylation, d...
Main Authors: | Olaia Martínez-Iglesias, Vinogran Naidoo, Iván Carrera, Juan Carlos Carril, Natalia Cacabelos, Ramón Cacabelos |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-7737/12/9/1156 |
Similar Items
-
Proteomic and Global DNA Methylation Modulation in Lipid Metabolism Disorders with a Marine-Derived Bioproduct
by: Olaia Martínez-Iglesias, et al.
Published: (2023-06-01) -
Natural Bioactive Products as Epigenetic Modulators for Treating Neurodegenerative Disorders
by: Olaia Martínez-Iglesias, et al.
Published: (2023-01-01) -
Nosustrophine: An Epinutraceutical Bioproduct with Effects on DNA Methylation, Histone Acetylation and Sirtuin Expression in Alzheimer’s Disease
by: Olaia Martínez-Iglesias, et al.
Published: (2022-11-01) -
DNA Methylation as a Biomarker for Monitoring Disease Outcome in Patients with Hypovitaminosis and Neurological Disorders
by: Olaia Martínez-Iglesias, et al.
Published: (2023-01-01) -
AntiGan: An Epinutraceutical Bioproduct with Antitumor Properties in Cultured Cell Lines
by: Olaia Martínez-Iglesias, et al.
Published: (2022-01-01)